UPDATE: Credit Suisse Reinstated Coverage on Tenet Healthcare (THC) at Outperform, Management Looks to Prove Itself

Credit Suisse is reinstating coverage on shares of Tenet Healthcare (NYSE: THC) with an Outperform rating and $7.50 price target.

The firm notes that rejecting Community's offer has placed management in a position to prove what they believe the company is worth.

The company has been experiencing margin expansion over the past couple of years do to some solid cost cutting and saving as top-line trends have lagged. Revenue did grow slightly in Q1, but so did costs. The firm believes the sustainability of top-line will be the key to outperformance by the company as it looks to leverage its successes in driving a lower cost base.

For more ratings news on Tenet Healthcare click here and for the rating history of Tenet Healthcare click here.

Shares of Tenet Healthcare closed at $6.28 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
• UBS Reiterates Buy Rating on Hilton Worldwide (HLT)
• Fiserv (FISV) PT Lowered to $60 at Freedom Broker